Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 10 crawled time : 16:00 save search
NLS Pharmaceutics Announces Technology Patent Grant Covering Mazindol for Treatment of Attention Deficit Hyperactivity Disorder and Rare Sleep Disorders in Hong Kong
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
NLSP | $0.1327 6.04% 74K
|
|
| O: 2.58%
H: 8.18%
C: 6.92%
treatment rare patent grant technology
SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
SOPH | $4.93 2.71% 2.64% 51K
|
|
| O: 7.14%
H: 10.83%
C: 6.67%
technology cancer
BrainStorm Cell Therapeutics Partners with NEALS, The ALS Association, and I AM ALS to Provide Public Access to Biospecimens from NurOwn's Phase 3 ALS Study
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -3.07%
H: 5.06%
C: 1.9%
als therapeutics study
Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
MLSS | $0.551 -3.57% 0.0% 68K
|
Health Technology
|
| O: -0.23%
H: 5.77%
C: 0.23%
system brazil milestone
Solid Biosciences Outlines Strategy for Leadership in Precision Genetic Medicines with Focus on Neuromuscular and Cardiac Diseases
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
SLDB | $8.7 -6.05% -6.44% 110K
|
Health Technology
|
| O: 1.5%
H: 0.16%
C: -2.3%
genetic cardiac
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 0.85%
H: 10.88%
C: 10.46%
conference
Cardiff Oncology to Present at B. Riley Securities' 3rd Annual Oncology Conference
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
CRDF | $4.34 -0.69% -0.69% 610K
|
Health Services
|
| O: 0.0%
H: 2.19%
C: 1.35%
conference
Qualigen Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for QN-302, a G-Quadruplex (G4) Transcription Inhibitor for the Intended Indication of Pancreatic Cancer
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
QLGN | $0.301 -3.43% -3.55% 30K
|
Health Technology
|
| O: 20.47%
H: 3.92%
C: -12.42%
qn-302 designation drug therapeutics food cancer pancreatic
Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
BMRA | $0.7459 -1.86% -1.89% 35K
|
Health Technology
|
| O: 1.76%
H: 2.31%
C: 2.31%
BIOLASE INC. ANNOUNCES PRICING OF APPROXIMATELY $9.75 MILLION UNDERWRITTEN PUBLIC OFFERING
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
BIOL | $0.1412 -4.92% -5.17% 1.4M
|
Health Technology
|
| O: -46.55%
H: 32.43%
C: 3.0%
offering
Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
EVO | $7.15 -0.7% 19K
|
Manufacturing
|
| O: 0.81%
H: 3.34%
C: 0.92%
SEOVF | $0.3295 15.67% 29K
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: -0.55%
diabetes potential
Sixth Wave Innovations Inc. expands their Valuable IP portfolio adding two ‘MIP’ patents for the Unique IXOS Metals Extraction and Purification System
Published: 2023-01-10 (Crawled : 16:00) - sixthwave.com
SIXWF | $0.0125 900.0% 5.2K
|
n/a
|
| O: -10.71%
H: 0.0%
C: -10.0%
ixos system unique
NTT DATA Business Solutions Partners with Aviatrix for Business-Critical Cloud Networking Infrastructure
Published: 2023-01-10 (Crawled : 16:00) - prnewswire.com
SAPGF | News | $181.104 -19.46% 1.2K
|
Technology Services
|
| O: 0.63%
H: 0.27%
C: 0.14%
SAP | News | $175.77 -1.61% 0.0% 950K
|
Technology Services
|
| O: 0.78%
H: 1.0%
C: 0.99%
solutions cloud
REV GROUP PUBLISHES 2022 CORPORATE SUSTAINABILITY REPORT
Published: 2023-01-10 (Crawled : 16:00) - revgroup.com
REVG A | $21.21 0.28% 0.28% 740K
|
Consumer Durables
|
| O: 0.0%
H: 1.8%
C: 0.76%
report group
Foundation Medicine Announces Collaboration with Karyopharm Therapeutics to Develop FoundationOne®CDx as a Companion Diagnostic for XPOVIO® (selinexor)
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -0.35%
H: 3.18%
C: 1.41%
foundationone collaboration diagnostic therapeutics
BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
TECH | $62.12 -0.15% -0.14% 910K
|
Health Technology
|
| O: 1.02%
H: 2.28%
C: 2.05%
plus therapy
Kymera Therapeutics Shares Key 2023 Goals to Support its Evolution into a Fully Integrated Degrader Medicines Company
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.78%
H: 9.65%
C: 8.3%
therapeutics
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
NARI S | $38.58 -0.16% -0.16% 790K
|
Health Technology
|
| O: 10.57%
H: 0.85%
C: -4.53%
medical
SAB Biotherapeutics Successfully Concludes IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
SABS | $4.46 0.22% 890
|
|
| O: 5.9%
H: 3.71%
C: -7.53%
sab-142 diabetes study
Tektronix Names Christopher Bohn President
Published: 2023-01-10 (Crawled : 16:00) - prnewswire.com
FTV | $79.49 -0.86% 0.0% 2.4M
|
Electronic Technology
|
| O: -0.29%
H: 1.01%
C: 0.76%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.